Biblio Discovery — Demo Discovery Service

18 hasil untuk "Utkarsh Goel"

Menampilkan 1–18 · 0,60 detik · RSS

  1. Artikel Jurnal

    Social media and the stock markets: an emerging market perspective

    Shweta Agarwal; Shailendra Kumar; Utkarsh Goel

    Journal of Business Economics and Management, Vol. 22 No. 6 · 2021 · Inggris · DOAJ Scopus

    There are numerous studies that examine the impact of social media on the stock market performance but there is a paucity of such evidences from the emerging economies. Today many multinational banks and other financial conglomerates from the developed countries are expanding their operations to…

  2. Artikel Jurnal

    Examining excessive stock market information search behavior: A moderating effect of age and gender

    Anubhav Srivastava; Shailendra Kumar; Utkarsh Goel

    Acta Psychologica, Vol. 263 · 2026 · Inggris · DOAJ Scopus

    Social media has improved the dissemination of information in the stock market. Several studies have measured substance use disorders associated with Internet and social media use using the Berger Facebook Addiction Scale. This investigation looked into excessive stock market information searches…

  3. Artikel Jurnal

    Unveiling the attitudinal factors: an integration of TPB and SCT in understanding investor intention towards equity investments

    Anurag Singh; Utkarsh Goel; Shailendra Kumar dkk.

    Humanities & Social Sciences Communications, Vol. 12 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract The growth of financial markets has facilitated individuals to invest in a wide range of securities and financial assets. As a result, behavioral finance has provided insight into traits and psychological factors that influence investors’ intentions and decisions. This paper investigates…

  4. Artikel Jurnal

    Factors affecting Information & Communication Technology (ICT) adoption among MSMEs

    Shailendra Kumar; Utkarsh Goel; Parikshit Joshi dkk.

    Journal of Open Innovation: Technology, Market and Complexity, Vol. 10 No. 1 · 2024 · Inggris · DOAJ Scopus

    The purpose of this study is to determine the factors influencing the Information & Communication Technology (ICT) adoption by the managers or owners of Micro, Small, and Medium Enterprises (MSME) operating in India. Based on two established theories of technology adoption - Technology acceptance…

  5. Artikel Jurnal

    Predictors of investment intention in real estate: Extending the theory of planned behavior

    Akshita Singh; Shailendra Kumar; Utkarsh Goel dkk.

    International Journal of Strategic Property Management, Vol. 28 No. 6 · 2024 · Inggris · DOAJ Scopus

    This paper explores the factors affecting the investment intention of individual real estate investors utilizing the extended theory of planned behavior. With the help of self-administered questionnaire, data from 366 individual investors from India was collected. This data was analysed using…

  6. Artikel Jurnal

    Behavioural biases in real estate investment: a literature review and future research agenda

    Akshita Singh; Shailendra Kumar; Utkarsh Goel dkk.

    Humanities & Social Sciences Communications, Vol. 10 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Psychological aspects of human nature cause behavioural biases and can lead to decisions that differ from what is expected based solely on rational analysis. The effects of behavioural biases on financial markets like stocks and mutual funds have been studied previously, but real estate…

  7. Artikel Jurnal

    Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

    Danai Dima; Al-Ola Abdallah; James A. Davis dkk.

    Blood Cancer Journal, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract The presence of extramedullary disease (EMD) has been associated with poor outcomes in patients with relapsed-refractory multiple myeloma (RRMM). Herein, we report the outcomes of RRMM patients who were treated with standard-of-care (SOC) chimeric antigen receptor (CAR) T-cell therapy and…

  8. Artikel Jurnal

    Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide

    Utkarsh Goel; Charalampos Charalampous; Prashant Kapoor dkk.

    Blood Cancer Journal, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Refractoriness to lenalidomide is an important factor determining the choice of therapy at first relapse in multiple myeloma (MM). It remains debatable if resistance to lenalidomide varies among MM refractory to standard doses vs low dose maintenance doses. In this study, we assessed the…

  9. Artikel Jurnal

    Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium

    Andrew J. Portuguese; James A. Davis; Shahzad Raza dkk.

    Blood Cancer Journal, Vol. 16 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Elranatamab, a BCMA-CD3 bispecific antibody, has demonstrated robust activity in relapsed/refractory multiple myeloma (RRMM), but real-world outcomes remain poorly defined. We conducted a multicenter retrospective study of 130 patients treated with commercial elranatamab across nine U.S…

  10. Artikel Jurnal

    Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment

    Danai Dima; Aimaz Afrough; Utkarsh Goel dkk.

    Blood Advances, Vol. 9 No. 14 · 2025 · Inggris · DOAJ Scopus

    Abstract: Outcomes of bispecific antibodies in patients with renal impairment (RI) are not well characterized, given the exclusion of these patients from clinical trials. Herein, we evaluated patients with relapsed/refractory multiple myeloma and RI treated with standard-of-care teclistamab. RI was…

  11. Artikel Jurnal

    Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

    Danai Dima; Mariola A. Vazquez-Martinez; James A. Davis dkk.

    Blood Cancer Journal, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Data describing outcomes of teclistamab in multiple myeloma patients with prior exposure to BCMA-directed therapy (BCMA-DT) are limited. The goal of this multicenter retrospective analysis was to report the efficacy and safety of standard-of-care teclistamab in patients with prior BCMA-DT…

  12. Artikel Jurnal

    The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience

    Aimaz Afrough; Danai Dima; Beatrice Razzo dkk.

    Blood Cancer Journal, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Teclistamab, a bispecific antibody targeting B-cell maturation antigen (BCMA), is effective in relapsed or refractory multiple myeloma (RRMM), but its impact on patients with soft tissue plasmacytomas is unclear. We studied 385 RRMM patients treated with teclistamab at 13 U.S. centers…

  13. Artikel Jurnal

    Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

    Oren Pasvolsky; Danai Dima; Lei Feng dkk.

    Blood Cancer Journal, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Teclistamab, a BCMA-directed bispecific antibody, received regulatory approval for relapsed/refractory multiple myeloma (RRMM) based on the MajesTEC-1 study. Despite the fact that myeloma is primarily a cancer of elderly adults, only 15% of MajesTEC-1 participants (n = 24) were ≥75 years…